QA: Arrowhead Pharmaceuticals INC in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000879407_2026_Arrowhead_Pharmaceuticals_INC.pdf

Logs

Graph

Absolute values for 0000879407, Arrowhead Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 950,639,000
1 IntangibleAssetsNetIncludingGoodwill 6,861,000
2 PropertyPlantAndEquipmentNet 382,515,000
3 remainder_Assets 45,280,000
4 LiabilitiesCurrent 195,487,000
5 LiabilitiesNoncurrent 686,392,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 127,331,269
9 ResearchAndDevelopmentExpense 939,242,732
10 remainder_Expenses 18,696,192
11 remainder_Revenues 4,756,055
12 remainder_NetIncome -55,183,123
13 remainder_ComprehensiveNetIncome 5,252,403
  yvar yval
0 Assets 1,385,295,000
1 Liabilities 881,879,000
2 Expenses 1,085,270,193
3 Revenues 4,756,055
4 StockholdersEquity 503,416,000
5 NetIncome -1,135,697,261
6 ComprehensiveNetIncome -1,133,071,060
7 BaseVar 1,708,817,887
8 EconomicCapitalRatiobeforeLimitedLiability -0.0314
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time